Patent Assignment
Reel/Frame 072061/0127
Assignment of Assignor's Interest
Recorded: 2025-08-19
Pages: 4
Assignors
PRESTRELSKI, STEVEN J.
Executed: 2017-08-31
KINZELL, JOHN
Executed: 2017-11-14
NEWSWANGER, BRETT
Executed: 2017-08-31
THORNTON, PAUL
Executed: 2017-08-31
STRANGE, POUL
Executed: 2017-08-31
CUMMINS, MARTIN
Executed: 2017-08-31
Assignee
XERIS PHARMACEUTICALS, INC.
3208 RED RIVER, SUITE 300, AUSTIN, TEXAS, 78705
Covered Property
(1)
Methods for Treating Congenital Hyperinsulinism
Application:
16/630,774 →
Publication:
US 2020/0147306
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Intellectual Property Security Agreement
May 4, 2021
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 056135/0800 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0714 →
Change of Address
Aug 29, 2025
From: XERIS PHARMACEUTICALS, INC.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 072771/0247 →